Recent studies have demonstrated that SOX2OT is overexpressed in many cancers and involved in tumor development and progression by acting as an oncogene to promote cell proliferation, invasion, migration, and growth and suppress cell apoptosis (118). This evidence concerns the gene SOX2-OT and neoplasm.